LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
LKFT
64 hedge funds and large institutions have $868M invested in Lakefront Biotherapeutics American Depositary Shares in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
23% more funds holding
Funds holding: 52 → 64 (+12)
0.18% more ownership
Funds ownership: 21.59% → 21.76% (+0.18%)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
Holders
64
Holding in Top 10
3
Calls
$19K
Puts
$9K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$7.61M | |
| 3 | +$4.16M | |
| 4 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$3.93M |
| 5 |
GAMA
Graticule Asia Macro Advisors
New York
|
+$2.88M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$7.56M | |
| 3 | -$3.1M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.45M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.39M |